Background: The etiology, treatment and prevention of Nonalcoholic fatty liver disease (NAFLD) after pancreatoduodenectomy (PD) remain largely unknown. We aimed to elucidate the risk factors for NAFLD after PD and investigate the nutritional effects of zinc medication. Methods: We retrospectively examined 109 patients who underwent PD between 2013 and 2017. We diagnosed the postoperative NAFLD using CT attenuation at six months later. We identified the risk factors for postoperative NAFLD among perioperative factors and analyzed the nutritional effect of zinc medication at six months after surgery. Results: We diagnosed 27 patients with NAFLD after PD. A univariate analysis showed that pancreas cancer (p = 0.029), operative time (p = 0.008), blood loss (p = 0.034), postoperative diarrhea (p < 0.001) and zinc medication (p < 0.001) were associated with postoperative NAFLD. A multivariate analysis demonstrated that zinc medication was the most important factor for the prevention of NAFLD after PD. All patients who received zinc also took pancreatic enzyme simultaneously and showed a significantly lower rate of body weight loss than in patients without zinc at six months after PD (p = 0.041). These patients showed a significantly higher total cholesterol level (p = 0.006) and higher serum zinc level (p<0.001). Furthermore, significantly fewer cases of postoperative NAFLD were noted among the patients who received zinc than among those who did not receive it (5.7% vs 33.8%: p = 0.001). Conclusion: These results suggest that zinc administration might improve the postoperative nutritional status and prevent NAFLD after PD.
| Published in | Journal of Surgery (Volume 7, Issue 5) |
| DOI | 10.11648/j.js.20190705.17 |
| Page(s) | 148-153 |
| Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
| Copyright |
Copyright © The Author(s), 2019. Published by Science Publishing Group |
Pancreatoduodenectomy, Nonalcoholic Fatty Liver Disease, Zinc
| [1] | Murakami Y, Uemura K, Hayashidani Y, Sudo T, Hashimoto Y, Nakagawara N, et al. No mortality after 150 consecutive pancreatoduodenectomies with duct-to-mucosa pancreaticogastrostomy. J Surg Oncol 2008; 97: 205-209. |
| [2] | Fish JC, Smith LB, Williams RD Digestive function after radical pancreaticoduodenectomy. Am J Surg 1969; 117: 40-45. |
| [3] | Nomura R, Ishizaki Y, Suzuki K, Kawasaki S. Development of hepatic steatosis after pancreatoduodenectomy. Am J Roentgenol 2007; 189: 1484-1488. |
| [4] | Yu HH, Shan YS, Lin PW Effect of pancreatticoduodenectomy on the course of hepatic steatosis. World J Surg 2010; 34: 2122-2127. |
| [5] | Kato H, Isaji S, Azumi Y, Kishiwada M, Hamada T Mizuno S, et al. Development of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) after pancreaticoduodenectomy: Proposal of a postoperative NAFLD scoring system. J Hepatobiliary Pancreat Sci 2010; 17: 296-304. |
| [6] | Tanaka N, Horiuchi A, Yokoyama T, Kaneko G, Horigome N, Yamura T, et al. Clinical characteristics of de novo nonalcoholic fatty liver disease following pancreaticoduodenectomy. J Gastroenterol 2011; 46: 758-768. |
| [7] | Sim EH, Kwon JH, Kim SY, Jung SM, Maeng LS, Jang JW, et al. Severe steatohepatitis with hepatic decompensation resulting from malnutrition after pancreaticoduodenectomy. Clin Mol Hepatol 2012; 18: 404-410. |
| [8] | Nakagawa N, Murakami Y, Uemura K, Sudo T, Hashimoto Y, Kondo N, et al. Nonalcoholic fatty liver disease after pancreatoduodenectomy is closely associated with postoperative pancreatic exocrine insufficiency. J Surg Oncol 2014; 110: 720-726. |
| [9] | Murata Y, Mizuno S, Kato H, Kishiwada M, Ohsawa I, Hamada T, et al. Nonalcoholic steatohepatitis (NASH) after pancreaticoduodenectomy: association of pancreatic exocrine deficiency and infection. Clin J Gastroenterol 2011; 4: 242-248. |
| [10] | Nagai M, Sho M, Satoi S, Toyokawa H, Akahori T, Yanagimoto H, et al. Effect of pancrelipase on nonalcoholic fatty liver disease after pancreaticoduodenectomy. J Hepatobililary Pancreat Sci 2014; 21: 186-192. |
| [11] | Kishi Y, Shimada K, Nara S, Esaki M, Kosuge T. Administration of pancrealipase as effective treatment for hepatic steatosis after pancreatectomy. Pancreas 2015; 44: 983-987. |
| [12] | Kato K, Isaji S, Kawarada Y, Hibasami H, Nakashima K. Effect of zinc administration on pancreatic regeneration after 80% pancreatectomy. Pancreas 1996; 14: 158-165. |
| [13] | Yu HH, Yang TM, Shan YS, Lin PW. Zinc deficiency in patients undergoing pancreatoduodenectomy for periampullary tumors is associated with pancreatic exocrine insufficiency. World J Surg 2011; 35: 2110-2117. |
| [14] | Sugino H, Kumagai N, Watanabe S, Toda K, Takeuchi O, Tsunematsu S, et al. Polaprezinc attenuates liver fibrosis in a mouse model of non-alcoholic steatohepatitis. J Gastroenterol Hepatol 2008; 23: 1909-1916. |
| [15] | Matsuoka S, Matsumura H, Nakamura H, Oshiro S, Arakawa Y, Hayashi J, et al. Zinc supplementation improves the outcome of chronic hepatitis C and liver cirrhosis. J Clin Biochem Nutr 2009; 45: 292-303. |
| [16] | Kawamoto S, Soyer PA, Fishman EK, Bluemke DA. Nonneoplatstic liver disease: Evaluation with CT and MRI imaging. Radiographics 1998; 18: 827-848. |
| [17] | Park SH, Kim PN, Kim KW, LEE SW, Yoon SE, Park SW, et al. Macrovesicular hepatic steatosis in living liver donors: Use of CT for quantitative and qualitative assessment. Radiology 2006; 239: 105-112. |
| [18] | Shrikhande SV, Sivasanker M, Vollmer CM, Friess H, Besselink MG, Fingerhut A, et al. International Study Group of Pancreatic Surgery (ISGPS) . Pancreatic anastomosis after pancreatoduodenectomy: A position statement by the International Study Group of Pancreatic Surgery (ISGPS) 2017; 161: 1221-1234. |
| [19] | Sato T, Matsuo Y, Shiga K, Morimoto M Miyai H, Takeyama H. Factors that predict the occurrence of and recovery from non-alcoholic fatty liver disease after pancreatoduodenectomy. Surgery 2016; 160: 318-330. |
| [20] | Satoi S, Sho M, Yanagimoto H, Yamamoto T, Akahori T, Kinoshita S, et al. Do pancrelipase delayed-release capsules have a protective role against nonalcoholic fattyliver disease after pancreatoduodenectomy in patients with pancreatic cancer? A randomized controlled trial. J Hepatobililary Pancreat Sci 2016; 23: 167-173. |
| [21] | Sturniolo Gc, Fries W, Mazzon E, Di Leo V, Barollo M, D’inca R. Effect of zinc supplementation on intestinal permeability in experimental colitis. J Lab Clin Med 2002; 139: 311-315. |
| [22] | Henning B, Wang Y, Ramasamy S, McClain CJ. Zinc deficiency alters barrier function of cultured porcine endothelial cells. J Nutr 1992; 122: 1242-1247. |
| [23] | Kim YJ, Kim MY, Kim HO, Lee MD, Park YM. Acrodematitis enteropathica-like eruption associated with combined nutritional deficiency. J Korean Med Sci2005; 20: 908-911. |
| [24] | Dutta SK, Procaccino F, Aamodt R Zinc metabolism in patienyts with exocrine pancreatic insufficiency. J Am Coll Nutr 1998; 17: 556-563. |
| [25] | Powell SR. The antioxidant properties of zinc. J Nutr 2000; 130: 1447S-1254S. |
| [26] | Yoshikawa T, Naito Y, Tanigawa T, Yoneta T, Kondo M. The antioxidant properties of a novel zinc-carnosine chelate compound, N- (3-aminopropionyl) -L-histidinato zinc. Biochem Biophys Acta 1991; 1115: 15-22. |
| [27] | Tilg H, Diehl AM. Cytokines in alcoholic and nonalcoholic steatohepatitis. N Engl J Med. 2000; 343: 1467-1476. |
| [28] | Kitade H, Chen G, Ni Y, Ota T. Nonalcoholic fatty liver disease and insulin resistance: New insights and potential new treatment. Nutrients 2017; 14: 9. |
APA Style
Atsushi Miyosh, Hiroki Koga, Satomi Nakamura, Hiroaki Nakamura, Kohei Yamada, et al. (2019). Effects of Zinc on Non-alcoholic Fatty Liver Disease After Pancreatoduodenectomy. Journal of Surgery, 7(5), 148-153. https://doi.org/10.11648/j.js.20190705.17
ACS Style
Atsushi Miyosh; Hiroki Koga; Satomi Nakamura; Hiroaki Nakamura; Kohei Yamada, et al. Effects of Zinc on Non-alcoholic Fatty Liver Disease After Pancreatoduodenectomy. J. Surg. 2019, 7(5), 148-153. doi: 10.11648/j.js.20190705.17
AMA Style
Atsushi Miyosh, Hiroki Koga, Satomi Nakamura, Hiroaki Nakamura, Kohei Yamada, et al. Effects of Zinc on Non-alcoholic Fatty Liver Disease After Pancreatoduodenectomy. J Surg. 2019;7(5):148-153. doi: 10.11648/j.js.20190705.17
Share This Article
Twitter
Linked In
Facebook
Copy
Download@article{10.11648/j.js.20190705.17,
author = {Atsushi Miyosh and Hiroki Koga and Satomi Nakamura and Hiroaki Nakamura and Kohei Yamada and Hiroshi Kubo and Masatsugu Hiraki and Osamu Ikeda and Toshiya Tanaka and Kenji Kitahara and Seiji Sato and Hirokazu Noshiro},
title = {Effects of Zinc on Non-alcoholic Fatty Liver Disease After Pancreatoduodenectomy},
journal = {Journal of Surgery},
volume = {7},
number = {5},
pages = {148-153},
doi = {10.11648/j.js.20190705.17},
url = {https://doi.org/10.11648/j.js.20190705.17},
eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.js.20190705.17},
abstract = {Background: The etiology, treatment and prevention of Nonalcoholic fatty liver disease (NAFLD) after pancreatoduodenectomy (PD) remain largely unknown. We aimed to elucidate the risk factors for NAFLD after PD and investigate the nutritional effects of zinc medication. Methods: We retrospectively examined 109 patients who underwent PD between 2013 and 2017. We diagnosed the postoperative NAFLD using CT attenuation at six months later. We identified the risk factors for postoperative NAFLD among perioperative factors and analyzed the nutritional effect of zinc medication at six months after surgery. Results: We diagnosed 27 patients with NAFLD after PD. A univariate analysis showed that pancreas cancer (p = 0.029), operative time (p = 0.008), blood loss (p = 0.034), postoperative diarrhea (p < 0.001) and zinc medication (p < 0.001) were associated with postoperative NAFLD. A multivariate analysis demonstrated that zinc medication was the most important factor for the prevention of NAFLD after PD. All patients who received zinc also took pancreatic enzyme simultaneously and showed a significantly lower rate of body weight loss than in patients without zinc at six months after PD (p = 0.041). These patients showed a significantly higher total cholesterol level (p = 0.006) and higher serum zinc level (p<0.001). Furthermore, significantly fewer cases of postoperative NAFLD were noted among the patients who received zinc than among those who did not receive it (5.7% vs 33.8%: p = 0.001). Conclusion: These results suggest that zinc administration might improve the postoperative nutritional status and prevent NAFLD after PD.},
year = {2019}
}
TY - JOUR T1 - Effects of Zinc on Non-alcoholic Fatty Liver Disease After Pancreatoduodenectomy AU - Atsushi Miyosh AU - Hiroki Koga AU - Satomi Nakamura AU - Hiroaki Nakamura AU - Kohei Yamada AU - Hiroshi Kubo AU - Masatsugu Hiraki AU - Osamu Ikeda AU - Toshiya Tanaka AU - Kenji Kitahara AU - Seiji Sato AU - Hirokazu Noshiro Y1 - 2019/09/26 PY - 2019 N1 - https://doi.org/10.11648/j.js.20190705.17 DO - 10.11648/j.js.20190705.17 T2 - Journal of Surgery JF - Journal of Surgery JO - Journal of Surgery SP - 148 EP - 153 PB - Science Publishing Group SN - 2330-0930 UR - https://doi.org/10.11648/j.js.20190705.17 AB - Background: The etiology, treatment and prevention of Nonalcoholic fatty liver disease (NAFLD) after pancreatoduodenectomy (PD) remain largely unknown. We aimed to elucidate the risk factors for NAFLD after PD and investigate the nutritional effects of zinc medication. Methods: We retrospectively examined 109 patients who underwent PD between 2013 and 2017. We diagnosed the postoperative NAFLD using CT attenuation at six months later. We identified the risk factors for postoperative NAFLD among perioperative factors and analyzed the nutritional effect of zinc medication at six months after surgery. Results: We diagnosed 27 patients with NAFLD after PD. A univariate analysis showed that pancreas cancer (p = 0.029), operative time (p = 0.008), blood loss (p = 0.034), postoperative diarrhea (p < 0.001) and zinc medication (p < 0.001) were associated with postoperative NAFLD. A multivariate analysis demonstrated that zinc medication was the most important factor for the prevention of NAFLD after PD. All patients who received zinc also took pancreatic enzyme simultaneously and showed a significantly lower rate of body weight loss than in patients without zinc at six months after PD (p = 0.041). These patients showed a significantly higher total cholesterol level (p = 0.006) and higher serum zinc level (p<0.001). Furthermore, significantly fewer cases of postoperative NAFLD were noted among the patients who received zinc than among those who did not receive it (5.7% vs 33.8%: p = 0.001). Conclusion: These results suggest that zinc administration might improve the postoperative nutritional status and prevent NAFLD after PD. VL - 7 IS - 5 ER -
Email: